Study of KN046 With Chemotherapy in First Line Advanced NSCLC
Status:
Unknown status
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This is a phase II study of KN046 plus platinum-based doublet chemotherapy in previously
untreated advanced non-squamous and squamous NSCLC subjects.
The study will assess primarily the safety and efficacy of KN046 plus platinum-based doublet
chemotherapy.